...
首页> 外文期刊>Chest: The Journal of Circulation, Respiration and Related Systems >Talc Pleurodesis Through Indwelling Pleural Catheters for Malignant Pleural Effusions Retrospective Case Series of a Novel Clinical Pathway
【24h】

Talc Pleurodesis Through Indwelling Pleural Catheters for Malignant Pleural Effusions Retrospective Case Series of a Novel Clinical Pathway

机译:通过留置胸膜导管滑石粉治疗恶性胸腔积液的新型临床途径回顾性病例系列

获取原文
获取原文并翻译 | 示例

摘要

Malignant pleural effusions cause significant morbidity, but there is no gold standard minimally invasive treatment. A new therapeutic approach combines talc pleurodesis and indwelling pleural catheters (IPCs) to enable outpatient management. This case series summarizes the safety and efficacy data of all patients (24) with a symptomatic malignant pleural effusion who underwent talc pleurodeses via IPCs between December 2010 and July 2013. Successful pleurodesis was achieved in 22 procedures (92%). There was one empyema, one hydropneumothorax, one recurrent effusion, and two minor complications: one drain site wound infection and one complaint of chest pain. Twenty-two procedures (92%) were performed in the outpatient setting. This report confirms the safety and efficacy of administering talc slurry through IPCs in an outpatient setting. Studies in a larger cohort are necessary to define the role of this novel approach in the treatment algorithm of patients with this condition.
机译:恶性胸腔积液可导致严重的发病,但尚无金标准的微创治疗方法。一种新的治疗方法结合了滑石粉胸膜固定术和留置胸膜导管(IPC)来实现门诊治疗。本病例系列总结了2010年12月至2013年7月间通过IPC接受滑石粉胸膜固定术的所有有症状恶性胸腔积液患者(24)的安全性和有效性数据。22例手术成功实现了胸膜固定术(92%)。有1例脓胸,1例气胸,1次反复积液和2例轻微并发症:1例引流部位伤口感染和1例胸痛。在门诊患者中进行了22例检查(占92%)。该报告证实了在门诊患者中通过IPC施用滑石粉的安全性和有效性。为了确定这种新方法在这种情况下的治疗算法中的作用,有必要进行更大范围的研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号